Skip to main content

Appeal Against Dismissal Of Purdue Pharma Lawsuits

Appeal Against Dismissal Of Purdue Pharma Lawsuits

Appeal Against Dismissal Of Purdue Pharma Lawsuits

Introduction

On May 14, 2019, the North Dakota Attorney General, Wayne Stenehjem, informed that the state would appeal against the dismissal of its suit alleging that Purdue Pharma fueled the opioid crisis.

The state along with 39 other state attorneys has sued Purdue Pharma over the opioid crisis a year ago. According to North Dakota District Judge James Hill, the claims in North Dakota's suit against Purdue attempted to mislead the benefits of long-term opioid use were barred by federal law. Also, they didn't allege any information that could provide a basis for Purdue to change its labeling without the approval of the U.S. Food and Drug Administration.

More than 1,600 cases over the opioid crisis are filed largely by local governments, Native American tribes, and hospitals. The first trial in the MDL No. 2804 is set to start in October 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!